The Hotel That Lets You Book a Room Based on Feelings
*By Samantha Errico*
A new luxury hotel in St. Louis, Missouri has a room to suit your mood.
The Angad Arts Hotel is a boutique hotel in the Arts District of St. Louis and features a slate of rooms colored to compliment guests' moods ー green for rejuvenation, yellow for happiness, red for passion, blue for tranquility.
"Traditionally, hotels are designed to meet everyone's needs so they are in neutral colors. We thought rather than be neutral colors, lets really saturate the rooms in color," Steve Smith, CEO of The Lawrence Group, told Cheddar Friday.
Along with choosing the color, guests are able to select the size of their rooms ー S, M, L, XL, and XXL.
Smith renovated a historic theater building, which was originally home to the iconic Rockettes before they relocated to Radio City Music Hal in Manhattan, N.Y.
The colors aren't the only quirk: the hotel's lobby is located on the 12th floor and the front door leads to the back of the building.
According to Smith, the space was also designed to showcase digital art installations constructed by local talent.
"We think about art in seeing the world in a different way and so we challenged ourselves with every design aspect of this hotel," Smith said.
For full itnerview [click here](https://cheddar.com/videos/the-angad-arts-hotel-lets-you-chose-a-room-based-on-your-mood).
Skift Editor-In-Chief Sarah Kopit discusses how summer travel plans remain uncertain for most as many international travelers are leery to travel abroad. Watch!
Seth Schachner, Managing Director at Strat Americas, on Hollywood's latest blockbusters utilizing content creation. Plus, the future of YouTube and TikTok.
Ashley Gold, Axios' Tech/Policy reporter, discusses what the future of Google and search engines will look like after the tech giant faces an antitrust trial.
Seth Goldstein, Equity Strategist at Morningstar, breaks down Tesla's earnings report, talks Musk's future with the company and how stocks have responded.
Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may change the healthcare industry.
